Bupropion-related parkinsonism and dystonia

Journal of Clinical Psychopharmacology

Volumn 29, Issue 6, 2009, Pages 616-618

  Cheng, Wan Chen ^a   Liu, Chih Min ^a   Hsieh, Ming H ^a   Hwang, Tzung Jeng ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BIPERIDEN; ESTAZOLAM; MIRTAZAPINE; OLANZAPINE; VENLAFAXINE;

AGED; AIRWAY OBSTRUCTION; AKATHISIA; BIOCHEMISTRY; BLOOD EXAMINATION; CASE REPORT; CHINESE; CONVALESCENCE; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FALLING; FEMALE; GAIT DISORDER; GERIATRIC CARE; HAND TREMOR; HOSPITAL ADMISSION; HUMAN; LETTER; MAJOR DEPRESSION; MELANCHOLIA; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; ONSET AGE; PARKINSONISM; PRIORITY JOURNAL; PSYCHOSIS; RELAPSE; SCORING SYSTEM; THYROID FUNCTION TEST; TREATMENT DURATION; TREMOR;

AGED; BUPROPION; DYSTONIA; FEMALE; HUMANS; PARKINSON DISEASE, SECONDARY;

EID: 72949116837     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181c07a3f     Document Type: Letter

References (13)

1. Detweiler MB, Harpold GJ. Bupropion-induced acute dystonia. Ann Pharmacother. 2002;36:251-254.
2. Gardos G. Reversible dyskinesia during bupropion therapy. J Clin Psychiatry. 1997;58:218.
3. Grandas F, Lopez-Manzanares L. Bupropion-induced parkinsonism. Mov Disord. 2007;22:1830-1831.
4. Jerome L. Bupropion and drug-induced parkinsonism. Can J Psychiatry. 2001;46:560-561.
5. Strouse TB, Salehmoghaddam S, Spar JE. Acute delirium and parkinsonism in a bupropion-treated liver transplant recipient. J Clin Psychiatry. 1993;54:489-490.
6. Szuba MP, Leuchter AF. Falling backward in two elderly patients taking bupropion. J Clin Psychiatry. 1992;53:157-159.
7. de Graaf L, Admiraal P, van Puijenbroek EP. Ballism associated with bupropion use. Ann Pharmacother. 2003;37:302-303.
8. Kohen I, Sarcevic A. Mirtazapine in bupropion-induced dyskinesias: a case report Mov Disord. 2006;21:584-585.
9. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245.
10. Meyer JH, Goulding VS, Wilson AA, et al. Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacology (Berl). 2002;163: 102-105.
11. El Mansari M, Ghanbari R, Janssen S, et al. Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain. Neuropharmacology. 2008.
12. Kennedy SH, McCann SM, Masellis M, et al Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary repor on pharmacokinetic, therapeutic, and sexual dysfunction effects. J Clin Psychiatry. 2002; 63:181-186.
13. Golden RN. Diethylpropion, bupropion, and psychoses. Br J Psychiatry. 1988;153: 265-266.